Health Outcomes Sciences

What Health Outcomes Sciences does

Health Outcomes Sciences operates as Terumo Health Outcomes, a US-based subsidiary of Japan's Terumo Group (TSE: 4543), focused on delivering AI-based clinical decision support to healthcare systems and hospitals. Its core product, ePRISM, integrates directly with hospital Electronic Health Records (EHR) platforms to analyze large volumes of patient data and provide prospective, personalized insights that anticipate patient needs, distinguish the platform from retrospective analytics alternatives. The company complements ePRISM with adjacent offerings including FDA-cleared Medis QFR 3.0 software for coronary physiology assessment and the VitalStream non-invasive hemodynamic monitoring product distributed through a partnership with Caretaker Medical. Services are organized around three pillars: improving patient outcomes, optimizing operations, and driving investment and cost savings for healthcare systems.

The business model centers on enterprise B2B sales of health intelligence software to US healthcare systems and hospitals, with revenue described as subscription/recurring in nature. Go-to-market combines direct enterprise field sales with channel/distribution agreements (notably Caretaker Medical and Medis), and the company employs a content-driven digital marketing approach through its website, blog, and resources center. Pricing is not publicly disclosed; sales are handled through direct contact with prospective healthcare organizations.

The company is small (11-50 employees), founded in 2010, headquartered in Somerset, New Jersey (with a Phoenix presence noted in firmographics), and operates exclusively in the US market. It has raised approximately $18.6M in disclosed funding across four rounds between 2011 and 2019, and operates as part of Terumo Group's broader medical technology portfolio, leveraging the parent's scale, brand credibility, and healthcare system relationships.

Name

Health Outcomes Sciences

Legal name

Terumo Medical Corporation

Website

http://www.h-outcomes.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Health Outcomes Sciences (Terumo Health Outcomes) provides ePRISM, an AI-based clinical decision support platform that integrates with hospital EHRs to deliver predictive, personalized care insights for US healthcare systems. The Terumo Group subsidiary also distributes cardiac and monitoring products.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Sepsis, Deterioration & Rapid Response CDS (HLACAGAF)

akta.pro secondary industry

Utilization Management, Appropriateness Criteria & Prior Authorization CDS (HLACAGAM)

Keywords

• Clinical decision support
• Healthcare predictive analytics
• EHR integration platform
• Care pathway optimization
• Health intelligence software

Headquarters

HQ city

Phoenix

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Healthcare Technology Solutions: Revenue generated through sale of AI-based clinical decision support technology and health intelligence solutions to healthcare systems and hospitals.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Health Outcomes Sciences (operating as Terumo Health Outcomes) sells the ePRISM AI-based clinical decision support (CDS) platform, which integrates with hospital Electronic Health Record (EHR) systems to analyze large volumes of patient data and provide prospective, personalized care recommendations to clinicians. The company complements this core platform with FDA-cleared Medis QFR 3.0 coronary physiology assessment software and the distributed VitalStream non-invasive hemodynamic monitoring product, alongside service offerings in patient outcomes improvement, operations optimization, and investment/cost savings.

Product overview

Terumo Health Outcomes offers ePRISM as its core AI-based clinical decision support platform, which integrates with hospital Electronic Health Records to deliver personalized, predictive care insights. The platform is complemented by specialized modules including Medis QFR 3.0 (FDA-cleared coronary physiology assessment software) and VitalStream (non-invasive hemodynamic monitoring, distributed through partnership). The company's services are organized around three pillars: improving patient outcomes, optimizing operations, and driving investment/cost savings, all leveraging health intelligence to transform data into personalized care.

Differentiator

Problem solved

Functional benefit

Brands

• ePRISM: AI-based clinical decision support (CDS) system that analyzes large volumes of patient data from Electronic Health Records (EHR) to suggest next steps for treatments, indicate potential problems, enhance efficiency, and facilitate the work of healthcare providers.

Products and services

• ePRISM An AI-based clinical decision support (CDS) system that analyzes large volumes of patient data from Electronic Health Records to suggest next steps for treatments, indicate potential problems, and deliver personalized care recommendations to healthcare providers at hospitals and health systems.
• Improve Patient Outcomes
• Optimize Operations
• Investment and Cost Savings
• Medis QFR 3.0
• VitalStream

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Caretaker MedicalcoreChannel Partner/ Reseller/ DistributorTerumo Health Outcomes has entered into a distribution agreement to distribute Caretaker Medical's VitalStream Non-Invasive Hemodynamic Monitoring product. This partnership enables Terumo to expand its product portfolio offering non-invasive hemodynamic monitoring capabilities to healthcare providers.
• MediscoreTechnology or IntegrationTerumo Health Outcomes now offers FDA-cleared Medis QFR 3.0 Software for coronary physiology assessment in the US market. This technology integration provides advanced cardiac diagnostic capabilities to support clinical decision-making.

Recent moves5 records

Expansion highlights4 records

Direct peers

• Qventus: Qventus offers an AI-based operations platform for hospitals that automates patient flow, discharge planning, and care pathways, directly competing with ePRISM's prospective CDS and operational optimization capabilities.
• Health Catalyst: Health Catalyst sells a healthcare data and analytics platform, including AI-driven decision support and outcomes improvement tools, to hospitals and health systems—directly comparable to ePRISM's EHR-integrated, predictive CDS value proposition.
• Elsevier (ClinicalPath / Order Sets): Elsevier's ClinicalPath and order-set solutions provide evidence-based care-pathway and decision-support tools embedded in hospital EHRs, overlapping directly with ePRISM's care pathway and CDS focus.
• LeanTaaS: LeanTaaS provides AI-based optimization software for hospital operations (OR, infusion centers, inpatient flow), which overlaps with Health Outcomes Sciences' Optimize Operations service pillar and care-pathway positioning.
• Wolters Kluwer Health (UpToDate, Medi-Span): Wolters Kluwer delivers evidence-based clinical decision support and care-pathway solutions used by hospitals worldwide, competing with Health Outcomes Sciences in the EHR-integrated CDS category.
• Premier Inc. Premier's Performance Services and Applied Sciences division provides AI-driven benchmarking, clinical decision support, and performance improvement tools to healthcare systems, comparable to ePRISM's outcomes-improvement offering.

Emerging players

• Notable: Notable deploys AI-driven intelligent automation and decision support across hospital workflows, representing a younger, well-funded emerging player in the prospective hospital CDS and operations space.
• Cohere Health: Cohere Health applies AI to utilization management and prior authorization, an adjacent CDS use case that competes for the same hospital and payer decision-support budget as ePRISM.

Broad incumbents

• Epic Systems: Epic is the dominant hospital EHR vendor and increasingly embeds native CDS, analytics, and care-pathway functionality, representing the most significant competitive incumbent to any third-party CDS platform.
• Oracle Health (formerly Cerner): Oracle Health bundles CDS, population health, and analytics within its EHR platform, competing for the same hospital IT budget as ePRISM and able to undercut third-party CDS at the contract level.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ePRISM
• Facebookfacebook.com/houtcomes
• LinkedInlinkedin.com/company/health-outcomes-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Outcomes Sciences